A Phase 1, Randomized, Open-Label, Single Dose, 4-Way Crossover Study In Healthy Volunteers To Assess The Relative Bioavailability Of The Oral Powder In Capsule (PIC) And An Immediate Release (IR) Film-Coated Tablet Of PH-797804 In The Fed And Fasted State.

Trial Profile

A Phase 1, Randomized, Open-Label, Single Dose, 4-Way Crossover Study In Healthy Volunteers To Assess The Relative Bioavailability Of The Oral Powder In Capsule (PIC) And An Immediate Release (IR) Film-Coated Tablet Of PH-797804 In The Fed And Fasted State.

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 13 Mar 2015

At a glance

  • Drugs PH 797804 (Primary)
  • Indications Rheumatoid arthritis
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 20 May 2009 Actual initiation date changed from 1 Mar 2009 to 1 Feb 2009 as reported by ClinicalTrials.gov.
    • 06 Mar 2009 Planned initiation date changed from 1 Feb 2009 to 1 Mar 2009 as reported by ClinicalTrials.gov.
    • 24 Jan 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top